Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43,484 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of the everolimus-eluting stent on stent thrombosis: a meta-analysis of 13 randomized trials.
Baber U, Mehran R, Sharma SK, Brar S, Yu J, Suh JW, Kim HS, Park SJ, Kastrati A, de Waha A, Krishnan P, Moreno P, Sweeny J, Kim MC, Suleman J, Pyo R, Wiley J, Kovacic J, Kini AS, Dangas GD. Baber U, et al. Among authors: yu j. J Am Coll Cardiol. 2011 Oct 4;58(15):1569-77. doi: 10.1016/j.jacc.2011.06.049. Epub 2011 Sep 14. J Am Coll Cardiol. 2011. PMID: 21924575 Free article.
Incidence and angiographic characteristics of patients with apical ballooning syndrome (takotsubo/stress cardiomyopathy) in the HORIZONS-AMI trial: an analysis from a multicenter, international study of ST-elevation myocardial infarction.
Prasad A, Dangas G, Srinivasan M, Yu J, Gersh BJ, Mehran R, Stone GW. Prasad A, et al. Among authors: yu j. Catheter Cardiovasc Interv. 2014 Feb 15;83(3):343-8. doi: 10.1002/ccd.23441. Epub 2013 Oct 21. Catheter Cardiovasc Interv. 2014. PMID: 22121008 Clinical Trial.
Outcomes of patients treated with triple antithrombotic therapy after primary percutaneous coronary intervention for ST-elevation myocardial infarction (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
Nikolsky E, Mehran R, Dangas GD, Yu J, Parise H, Xu K, Pocock SJ, Stone GW. Nikolsky E, et al. Among authors: yu j. Am J Cardiol. 2012 Mar 15;109(6):831-8. doi: 10.1016/j.amjcard.2011.10.046. Epub 2011 Dec 22. Am J Cardiol. 2012. PMID: 22196778 Clinical Trial.
Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial).
Mehta RH, Yu J, Piccini JP, Tcheng JE, Farkouh ME, Reiffel J, Fahy M, Mehran R, Stone GW. Mehta RH, et al. Among authors: yu j. Am J Cardiol. 2012 Mar 15;109(6):805-12. doi: 10.1016/j.amjcard.2011.10.043. Epub 2011 Dec 22. Am J Cardiol. 2012. PMID: 22196782 Clinical Trial.
Comparison of abciximab versus eptifibatide during percutaneous coronary intervention in ST-segment elevation myocardial infarction (from the HORIZONS-AMI trial).
Singh HS, Dangas GD, Guagliumi G, Yu J, Witzenbichler B, Kornowski R, Grines C, Gersh B, Dudek D, Mehran R, Stone GW. Singh HS, et al. Among authors: yu j. Am J Cardiol. 2012 Oct 1;110(7):940-7. doi: 10.1016/j.amjcard.2012.05.026. Epub 2012 Jun 28. Am J Cardiol. 2012. PMID: 22748356 Clinical Trial.
Characteristics and outcomes of patients with ST-segment elevation myocardial infarction excluded from the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial.
Fiocca L, Guagliumi G, Rossini R, Parise H, Musumeci G, Sirbu V, Lortkipanidze N, Yu J, Mihalcsik L, Vassileva A, Valsecchi O, Gavazzi A, Mehran R, Stone GW. Fiocca L, et al. Among authors: yu j. Am J Cardiol. 2013 Jan 15;111(2):196-201. doi: 10.1016/j.amjcard.2012.09.019. Epub 2012 Oct 27. Am J Cardiol. 2013. PMID: 23111141 Clinical Trial.
43,484 results
You have reached the last available page of results. Please see the User Guide for more information.